RELAPSED B-CELL NHL

Clinical trials for RELAPSED B-CELL NHL explained in plain language.

Never miss a new study

Get alerted when new RELAPSED B-CELL NHL trials appear

Sign up with your email to follow new studies for RELAPSED B-CELL NHL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

First patients test promising new pill for Tough-to-Treat lymphoma

Disease control Ongoing

This is the first study in people testing a new oral medication called JNJ-88998377 for patients with B-cell non-Hodgkin's lymphoma that has returned or not responded to other treatments. The main goals are to check the drug's safety and figure out the best dose for future testin…

Matched conditions: RELAPSED B-CELL NHL

Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control

Last updated Mar 17, 2026 13:09 UTC

RELAPSED B-CELL NHL

Get alerted when new RELAPSED B-CELL NHL trials appear

First patients test promising new pill for Tough-to-Treat lymphoma